B-NDG hB2M/HLA-A3.1 mice plus_Biocytogen Pharmaceuticals (Beijing) Co., Ltd._Biocytogen, drug development, antibody discovery

top

Please input keywords

KR

사회적 책임

합작연구개발

Antibody Assets

Project Integrum

Antibody discovery platforms

Clinical pipeline

Preclinical pipeline

동물/세포 모델

Humanized animal models

KO mouse models

Immunodeficient mice/rats

Disease mouse models

Pharmacology service

Therapeutic area

Types of services

유전자 편집

By technologies

Animal Breeding

Animal Cryopreservation

Animal Rederivation

Microbial detection

Animal Breeding

Animal Cryopreservation

Animal Rederivation

Stock Information

Financial Reports

Listing Documents

Announcements & Notices

Corporate Governance

Investor Calendar

Order

*Country

한국

미국

일본

중국

영국

호주

프랑스

독일

이탈리아

싱가포르

인도

러시아

캐나다

스위스

기타 국가

*Province

*City

*Name

*Telephone

*Company

*Position

*Email

*Verification code

*Verification Code

동물/세포 모델

동물/세포모델

Immunodeficient Mice/Rats

Immunodeficient (B-NDG) Mice

B-NDG hB2M/HLA-A3.1 mice plus

Strain Name	NOD.CB17-Prkdc^scidIl2rg^tm1Bcgen B2m^{tm1(B2M/HLA-A3.1)Bcgen} Fcgrt^{tm1(B2m/Fcgrt)Bcgen}/Bcgen	Common Name	B-NDG hB2M/HLA-A3.1 mice plus
Background	B-NDG mice	Catalog number	112873
Related Genes	B2m (beta-2 microglobulin) ; Fcgrt (Fc receptor, IgG, alpha chain transporter,as known as Fcrn); B2m: Ly-m11, beta2-m, beta2m HLA-A: HLAA
NCBI Gene ID	14132,12010,16186,19090

该动物由B-NDG B2m KO mice plus(110601)和B-NDG hB2M/HLA-A3.1 mice(112450)交配获得,可参考相关单基因产品验证数据。